| 000 | 01488 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511183650.0 | ||
| 264 | 0 | _c19921211 | |
| 008 | 199212s 0 0 ger d | ||
| 022 | _a0012-0472 | ||
| 024 | 7 |
_a10.1055/s-2008-1062503 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeschner, M | |
| 245 | 0 | 0 |
_a[Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects]. _h[electronic resource] |
| 260 |
_bDeutsche medizinische Wochenschrift (1946) _cNov 1992 |
||
| 300 |
_a1730-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlbuminuria _xetiology |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xenzymology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
| 650 | 0 | 4 |
_aEndopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aFurosemide _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Glomerulus _xenzymology |
| 650 | 0 | 4 |
_aMetoprolol _xtherapeutic use |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aSchaefer, R M | |
| 700 | 1 | _aBahner, U | |
| 700 | 1 | _aHeidland, A | |
| 773 | 0 |
_tDeutsche medizinische Wochenschrift (1946) _gvol. 117 _gno. 45 _gp. 1730-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2008-1062503 _zAvailable from publisher's website |
| 999 |
_c1431775 _d1431775 |
||